Xenobiotica

Papers
(The H4-Index of Xenobiotica is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Expression of cytochrome P450 isozyme transcripts and activities in human livers31
Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens25
Amalgamation of in-silico, in-vitro and in-vivo approach to establish glabridin as a potential CYP2E1 inhibitor16
In silico prediction of volume of distribution of drugs in man using conformal prediction performs on par with animal data-based models15
Pharmacokinetics, tissue distribution and excretion of five rhubarb anthraquinones in rats after oral administration of effective fraction of anthraquinones from rheum officinale15
Comparison between lab variability andin silicoprediction errors for the unbound fraction of drugs in human plasma15
FXR activation prevents liver injury induced byTripterygium wilfordiipreparations13
Oral bioavailability and pharmacokinetics of esculetin following intravenous and oral administration in rats13
Methyl-hydroxylation and subsequent oxidation to produce carboxylic acid is the major metabolic pathway of tolbutamide in chimeric TK-NOG mice transplanted with human hepatocytes12
Role of human flavin-containing monooxygenase (FMO) 5 in the metabolism of nabumetone: Baeyer–Villiger oxidation in the activation of the intermediate metabolite, 3-hydroxy nabumetone, to the active m12
Metal-metal interaction and metal toxicity: a comparison between mammalian and D. melanogaster11
Pharmacokinetics and metabolism of brexpiprazole, a novel serotonin-dopamine activity modulator and its main metabolite in rat, monkey and human11
Newly identified tree shrew cytochrome P450 2B6 (CYP2B6) and pig CYP2B6b are functional drug-metabolising enzymes11
0.034187793731689